Latest news
Loading news…
Cellartis
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Göteborg, Vastra Gotaland, Sweden Founded 2001 51-100 employees For Profit
Cellartis develops human embryonic stem cells and technology for drug discovery research, toxicity testing and regenerative medicine.
Cellartis was acquired by Cellectis in 2011.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
13
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 0
- Patents granted
- 13
- Trademarks
- 0
- Top patent class
- Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering
- IT spend
- $9M
Company Info
- Founded
- 2001
- Employees
- 51-100
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Göteborg, Vastra Gotaland, Sweden
- Region
- European Union (EU), Nordic Countries, Scandinavia
- Exit date
- Sep 15, 2011
Signals & Scores
- Heat score
- Medium
- Growth score
- Low
- Trend (7d)
- -0.1
- Trend (30d)
- -0.5
- Trend (90d)
- -0.9
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Cellartis
Loading news…
FAQs about Cellartis
People who checked this page also checked these
Browse the full Acquirezy directory.